Biotoxtech Co. Ltd.

Biotoxtech Co. Ltd. operates as a leading non-clinical contract research organization (CRO) specializing in safety evaluation in South Korea. The company's primary function is to provide comprehensive toxicology assessment for pharmaceuticals, chemicals, and biotechnological products, ensuring their safety and compliance prior to regulatory approval. Biotoxtech is known for its in-depth testing procedures and state-of-the-art facilities that cater to the complex needs of various industries such as pharmaceuticals, biotechnology, agrochemicals, and food. By conducting animal testing and mechanistic studies, it aids in determining the safety and efficacy of new compounds. Biotoxtech's role in the financial market is significant as it serves as a pivotal link in the development chain of new medical and chemical products, thus influencing the broader health and agricultural sectors. Founded in 2000 and headquartered in Cheongju, the company has carved a niche by providing crucial data required for product development decisions, regulatory submissions, and market entry strategies, making it an integral part of the life sciences industry value chain.